Roivant Sciences Ltd (ROIV) stock news · rev $8.3M
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
This ROIV news page leads with what Roivant Sciences Ltd filed — not a scraped headline mill.
No cached 8-K sentence for ROIV yet. We will not pad this page with generic market recap.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 93.4% from 2024-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ROIV stock page; for the tape open the quote page.
ROIV stock news FAQ
What are ROIV's latest revenue and net income?
Latest cached Roivant Sciences Ltd (ROIV) revenue for Mar 31, 2026 was $8.3M. Net income was -$299.8M. Statements: https://lician.com/financials/roiv
How did ROIV revenue change from the prior cached period?
Cached Roivant Sciences Ltd (ROIV) revenue was down 93.4% from $124.8M (Mar 31, 2024) to $8.3M (Mar 31, 2026). Statements: https://lician.com/financials/roiv
What is ROIV's market cap?
Roivant Sciences Ltd (ROIV) market cap is $7.47B on the latest cached fundamentals snapshot.
What kind of company is ROIV?
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Where is ROIV stock news listed?
Cached stock news for Roivant Sciences Ltd (ROIV) is listed at https://lician.com/news/roiv. Filings: https://lician.com/sec/roiv
Not investment advice.